Doyle Anthony

Number of records: 9
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
15-May-24 7:19 AM
View: 
BioCryst Pharmaceuticals Inc. (BCRX) 14-May-24Private Purchase 36,300$5.57$202,191.0016%
230.44K to 266.74K
20-Dec-23 4:35 PM
View: 
BioCryst Pharmaceuticals Inc. (BCRX) 19-Dec-23Payment of Exercise 2,482$6.05$15,016.10(1%)
229.93K to 227.44K
18-Dec-23 4:37 PM
View: 
BioCryst Pharmaceuticals Inc. (BCRX) 14-Dec-23Grant 34,000----17%
201.4K to 235.4K
18-Dec-23 4:37 PM
View: 
BioCryst Pharmaceuticals Inc. (BCRX) 14-Dec-23Payment of Exercise 5,475$6.43$35,204.20(2%)
235.4K to 229.93K
21-Dec-22 4:32 PM
View: 
BioCryst Pharmaceuticals Inc. (BCRX) 19-Dec-22Grant 34,000----21%
163.97K to 197.97K
19-Dec-22 4:55 PM
View: 
BioCryst Pharmaceuticals Inc. (BCRX) 15-Dec-22Sale 5,700$10.90$62,130.00(3%)
169.67K to 163.97K
16-Dec-21 4:59 PM
View: 
BioCryst Pharmaceuticals Inc. (BCRX) 14-Dec-21Grant 115,000----123%
93.72K to 208.72K
24-Nov-21 6:35 PM
View: 
BioCryst Pharmaceuticals Inc. (BCRX) 23-Nov-21Market Purchase 35,258$12.48$440,020.0060%
58.46K to 93.72K
(< 1%)
12-Aug-20 4:31 PM
View: 
BioCryst Pharmaceuticals Inc. (BCRX) 11-Aug-20Market Purchase 54,000$4.08$220,320.00100%
0 to 54.0K
86%